Literature DB >> 23536399

Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries.

Brianna Lindsay1, John B Ochieng, Usman N Ikumapayi, Aliou Toure, Dilruba Ahmed, Shan Li, Sandra Panchalingam, Myron M Levine, Karen Kotloff, David A Rasko, Carolyn R Morris, Jane Juma, Barry S Fields, Michel Dione, Dramane Malle, Stephen M Becker, Eric R Houpt, James P Nataro, Halvor Sommerfelt, Mihai Pop, Joe Oundo, Martin Antonio, Anowar Hossain, Boubou Tamboura, O Colin Stine.   

Abstract

Estimates of the prevalence of Shigella spp. are limited by the suboptimal sensitivity of current diagnostic and surveillance methods. We used a quantitative PCR (qPCR) assay to detect Shigella in the stool samples of 3,533 children aged <59 months from the Gambia, Mali, Kenya, and Bangladesh, with or without moderate-to-severe diarrhea (MSD). We compared the results from conventional culture to those from qPCR for the Shigella ipaH gene. Using MSD as the reference standard, we determined the optimal cutpoint to be 2.9 × 10(4) ipaH copies per 100 ng of stool DNA for set 1 (n = 877). One hundred fifty-eight (18%) specimens yielded >2.9 × 10(4) ipaH copies. Ninety (10%) specimens were positive by traditional culture for Shigella. Individuals with ≥ 2.9 × 10(4) ipaH copies have 5.6-times-higher odds of having diarrhea than those with <2.9 × 10(4) ipaH copies (95% confidence interval, 3.7 to 8.5; P < 0.0001). Nearly identical results were found using an independent set of samples. qPCR detected 155 additional MSD cases with high copy numbers of ipaH, a 90% increase from the 172 cases detected by culture in both samples. Among a subset (n = 2,874) comprising MSD cases and their age-, gender-, and location-matched controls, the fraction of MSD cases that were attributable to Shigella infection increased from 9.6% (n = 129) for culture to 17.6% (n = 262) for qPCR when employing our cutpoint. We suggest that qPCR with a cutpoint of approximately 1.4 × 10(4) ipaH copies be the new reference standard for the detection and diagnosis of shigellosis in children in low-income countries. The acceptance of this new standard would substantially increase the fraction of MSD cases that are attributable to Shigella.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536399      PMCID: PMC3716050          DOI: 10.1128/JCM.02713-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Evaluation of nucleic acid amplification tests in the absence of a perfect gold-standard test: a review of the statistical and epidemiologic issues.

Authors:  Alula Hadgu; Nandini Dendukuri; Joergen Hilden
Journal:  Epidemiology       Date:  2005-09       Impact factor: 4.822

2.  Pathogenicity of Shigella in healthy carriers: a study in Vientiane, Lao People's Democratic Republic.

Authors:  Bounnanh Phantouamath; Noikaseumsy Sithivong; Sithat Insisiengmay; Yoshio Ichinose; Naomi Higa; Tianyan Song; Masaaki Iwanaga
Journal:  Jpn J Infect Dis       Date:  2005-08       Impact factor: 1.362

Review 3.  Understanding diagnostic tests 3: Receiver operating characteristic curves.

Authors:  Anthony K Akobeng
Journal:  Acta Paediatr       Date:  2007-03-21       Impact factor: 2.299

4.  Utility of a polymerase chain reaction diagnostic system in a study of the epidemiology of shigellosis among dysentery patients, family contacts, and well controls living in a shigellosis-endemic area.

Authors:  P A Gaudio; O Sethabutr; P Echeverria; C W Hoge
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

5.  Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111.

Authors:  C O Tacket; K L Kotloff; G Losonsky; J P Nataro; J Michalski; J B Kaper; R Edelman; M M Levine
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

6.  Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.

Authors:  D N Taylor; C O Tacket; G Losonsky; O Castro; J Gutierrez; R Meza; J P Nataro; J B Kaper; S S Wasserman; R Edelman; M M Levine; S J Cryz
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

7.  A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity.

Authors:  K L Kotloff; J P Nataro; G A Losonsky; S S Wasserman; T L Hale; D N Taylor; J C Sadoff; M M Levine
Journal:  Vaccine       Date:  1995-11       Impact factor: 3.641

8.  Detection of Shigella by a PCR assay targeting the ipaH gene suggests increased prevalence of shigellosis in Nha Trang, Vietnam.

Authors:  Dinh Thiem Vu; Orntipa Sethabutr; Lorenz Von Seidlein; Van Tung Tran; Gia Canh Do; Trong Chien Bui; Huu Tho Le; Hyejon Lee; Huo-Shu Houng; Thomas L Hale; John D Clemens; Carl Mason; Duc Trach Dang
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  Factors that explain excretion of enteric pathogens by persons without diarrhea.

Authors:  Myron M Levine; Roy M Robins-Browne
Journal:  Clin Infect Dis       Date:  2012-12       Impact factor: 9.079

10.  A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology.

Authors:  Lorenz von Seidlein; Deok Ryun Kim; Mohammad Ali; Hyejon Lee; Xuanyi Wang; Vu Dinh Thiem; Do Gia Canh; Wanpen Chaicumpa; Magdarina D Agtini; Anowar Hossain; Zulfiqar A Bhutta; Carl Mason; Ornthipa Sethabutr; Kaisar Talukder; G B Nair; Jacqueline L Deen; Karen Kotloff; John Clemens
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

View more
  46 in total

1.  Genome diversity of Shigella boydii.

Authors:  Dane A Kania; Tracy H Hazen; Anowar Hossain; James P Nataro; David A Rasko
Journal:  Pathog Dis       Date:  2016-04-06       Impact factor: 3.166

2.  Real-time PCR threshold cycle cutoffs help to identify agents causing acute childhood diarrhea in Zanzibar.

Authors:  Kristina Elfving; Maria Andersson; Mwinyi I Msellem; Christina Welinder-Olsson; Max Petzold; Anders Björkman; Birger Trollfors; Andreas Mårtensson; Magnus Lindh
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

3.  Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.

Authors:  BreOnna C DeLaine; Tao Wu; Christen L Grassel; Avital Shimanovich; Marcela F Pasetti; Myron M Levine; Eileen M Barry
Journal:  Pathog Dis       Date:  2016-04-21       Impact factor: 3.166

4.  In Silico Serotyping Based on Whole-Genome Sequencing Improves the Accuracy of Shigella Identification.

Authors:  Yun Wu; Henry K Lau; Teresa Lee; David K Lau; Justin Payne
Journal:  Appl Environ Microbiol       Date:  2019-03-22       Impact factor: 4.792

5.  Defining the phylogenomics of Shigella species: a pathway to diagnostics.

Authors:  Jason W Sahl; Carolyn R Morris; Jennifer Emberger; Claire M Fraser; John Benjamin Ochieng; Jane Juma; Barry Fields; Robert F Breiman; Matthew Gilmour; James P Nataro; David A Rasko
Journal:  J Clin Microbiol       Date:  2015-01-14       Impact factor: 5.948

6.  Survey of culture, goldengate assay, universal biosensor assay, and 16S rRNA Gene sequencing as alternative methods of bacterial pathogen detection.

Authors:  Brianna Lindsay; Mihai Pop; Martin Antonio; Alan W Walker; Volker Mai; Dilruba Ahmed; Joseph Oundo; Boubou Tamboura; Sandra Panchalingam; Myron M Levine; Karen Kotloff; Shan Li; Laurence S Magder; Joseph N Paulson; Bo Liu; Usman Ikumapayi; Chinelo Ebruke; Michel Dione; Mitchell Adeyemi; Richard Rance; Mark D Stares; Maria Ukhanova; Bret Barnes; Ian Lewis; Firoz Ahmed; Meer Taifur Alam; Ruhul Amin; Sabbir Siddiqui; John B Ochieng; Emmanuel Ouma; Jane Juma; Eunice Mailu; Richard Omore; Ciara E O'Reilly; James Hannis; Sheri Manalili; Jonna Deleon; Irene Yasuda; Lawrence Blyn; Raymond Ranken; Feng Li; Roberta Housley; David J Ecker; M Anowar Hossain; Robert F Breiman; J Glenn Morris; Timothy K McDaniel; Julian Parkhill; Debasish Saha; Rangarajan Sampath; O Colin Stine; James P Nataro
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

Review 7.  Changes in microbiome during and after travellers' diarrhea: what we know and what we do not.

Authors:  David A Rasko
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

8.  Enteropathogenic Escherichia coli Infection in Cancer and Immunosuppressed Patients.

Authors:  Adilene Olvera; Hannah Carter; Anubama Rajan; Lily G Carlin; Xiaomin Yu; Xi-Lei Zeng; Samuel Shelburne; Micah Bhatti; Sarah E Blutt; Noah F Shroyer; Robert Jenq; Mary K Estes; Anthony Maresso; Pablo C Okhuysen
Journal:  Clin Infect Dis       Date:  2021-05-18       Impact factor: 9.079

9.  Association Between Shigella Infection and Diarrhea Varies Based on Location and Age of Children.

Authors:  Brianna Lindsay; Debasish Saha; Doh Sanogo; Sumon Kumar Das; Richard Omore; Tamer H Farag; Dilruba Nasrin; Shan Li; Sandra Panchalingam; Myron M Levine; Karen Kotloff; James P Nataro; Laurence Magder; Laura Hungerford; A S G Faruque; Joseph Oundo; M Anowar Hossain; Mitchell Adeyemi; Oscar Colin Stine
Journal:  Am J Trop Med Hyg       Date:  2015-08-31       Impact factor: 2.345

10.  Failure of Syndrome-Based Diarrhea Management Guidelines to Detect Shigella Infections in Kenyan Children.

Authors:  P B Pavlinac; D M Denno; G C John-Stewart; F M Onchiri; J M Naulikha; E A Odundo; C E Hulseberg; B O Singa; L E Manhart; J L Walson
Journal:  J Pediatric Infect Dis Soc       Date:  2015-07-12       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.